Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$620,000 |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$381M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$30,000 |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Haley Patrick J. | Mar 3, 2025 | Sell | 10,000 | $38.8 | $390,000 |
| Smith Julie | Feb 28, 2025 | Sell | 19,294 | $37.62 | $730,000 |
| WYSZOMIERSKI JACK L | Feb 28, 2025 | Sell | 8,768 | $37.8 | $330,000 |
| Smith Julie | Feb 27, 2025 | Sell | 54,514 | $38.13 | $2.1M |
| Oliver Bob | Feb 25, 2025 | Sell | 18,647 | $37.25 | $690,000 |
| Haley Patrick J. | Feb 24, 2025 | Sell | 52,636 | $36.98 | $1.9M |
| Aftab Dana | Feb 24, 2025 | Sell | 26,987 | $36.75 | $990,000 |
| Senner Christopher J. | Feb 24, 2025 | Sell | 29,314 | $36.14 | $1.1M |
| POSTE GEORGE | Feb 14, 2025 | Sell | 15,874 | $34.74 | $550,000 |
| Freire Maria C | Feb 14, 2025 | Sell | 44,114 | $34.94 | $1.5M |
| Beckerle Mary C | Feb 14, 2025 | Sell | 8,354 | $34.87 | $290,000 |
| Beckerle Mary C | Feb 14, 2025 | Sell | 3,856 | $34.9 | $130,000 |
| Eckhardt Sue Gail | Feb 14, 2025 | Sell | 7,712 | $35.01 | $270,000 |
| Eckhardt Sue Gail | Feb 14, 2025 | Sell | 3,856 | $35.04 | $140,000 |
| Hessekiel Jeffrey | Nov 29, 2024 | Sell | 60,000 | $36.67 | $2.2M |
| Haley Patrick J. | Nov 22, 2024 | Sell | 10,000 | $35.27 | $350,000 |
| Haley Patrick J. | Nov 18, 2024 | Sell | 22,207 | $34.31 | $760,000 |
| Haley Patrick J. | Nov 18, 2024 | Sell | 19,381 | $34.41 | $670,000 |
| Aftab Dana | Nov 5, 2024 | Sell | 96,986 | $35 | $3.4M |
| Hessekiel Jeffrey | Nov 1, 2024 | Sell | 50,000 | $34.13 | $1.7M |
| POSTE GEORGE | Nov 1, 2024 | Sell | 30,000 | $34 | $1M |
| Aftab Dana | Oct 30, 2024 | Sell | 1,162 | $31.4 | $36,000 |
| Hessekiel Jeffrey | Oct 28, 2024 | Sell | 25,000 | $28.39 | $710,000 |
| Hessekiel Jeffrey | Sep 23, 2024 | Sell | 25,000 | $26.38 | $660,000 |
| Hessekiel Jeffrey | Aug 26, 2024 | Sell | 20,000 | $25.79 | $520,000 |
| Freire Maria C | Aug 14, 2024 | Sell | 8,250 | $26.56 | $220,000 |
| Aftab Dana | Aug 12, 2024 | Sell | 20,883 | $27.06 | $570,000 |
| Senner Christopher J. | Aug 9, 2024 | Sell | 125,000 | $27.19 | $3.4M |
| POSTE GEORGE | Aug 8, 2024 | Sell | 33,725 | $26.89 | $910,000 |
| Aftab Dana | Aug 7, 2024 | Sell | 95,000 | $25 | $2.4M |
| Haley Patrick J. | Aug 7, 2024 | Sell | 14,000 | $25.5 | $360,000 |
| Hessekiel Jeffrey | Aug 7, 2024 | Sell | 80,000 | $25.97 | $2.1M |
| WYSZOMIERSKI JACK L | Jun 4, 2024 | Sell | 8,287 | $22 | $180,000 |
| Caligan Partners LP | May 30, 2024 | Buy | 225,000 | $20.7558 | $4.7M |
| Caligan Partners LP | May 28, 2024 | Buy | 200,000 | $20.3195 | $4.1M |
| Smith Julie | May 21, 2024 | Sell | 27,280 | $21.12 | $580,000 |
| POSTE GEORGE | May 21, 2024 | Sell | 11,686 | $20.96 | $240,000 |
| PAPADOPOULOS STELIOS | May 20, 2024 | Sell | 11,437 | $21 | $240,000 |
| WYSZOMIERSKI JACK L | May 13, 2024 | Sell | 10,923 | $21.37 | $230,000 |
| Garber Alan M | Mar 21, 2024 | Sell | 19,205 | $24.01 | $460,000 |
| Haley Patrick J. | Feb 23, 2024 | Sell | 47,020 | $21.45 | $1M |
| Caligan Partners LP | Feb 21, 2024 | Buy | 190,000 | $20.6986 | $3.9M |
| Haley Patrick J. | Dec 14, 2023 | Sell | 50,000 | $23.35 | $1.2M |
| Hessekiel Jeffrey | Dec 13, 2023 | Sell | 25,000 | $23.01 | $580,000 |
| Haley Patrick J. | Dec 12, 2023 | Sell | 14,149 | $22.5 | $320,000 |
| Hessekiel Jeffrey | Dec 4, 2023 | Sell | 25,000 | $22.06 | $550,000 |
| Caligan Partners LP | Nov 27, 2023 | Buy | 120,409 | $21.61 | $2.6M |
| Aftab Dana | Aug 30, 2023 | Sell | 4,600 | $22.47 | $100,000 |
| Senner Christopher J. | Aug 4, 2023 | Sell | 60,000 | $20.68 | $1.2M |
| Haley Patrick J. | Aug 3, 2023 | Sell | 30,553 | $20.67 | $630,000 |
| Hessekiel Jeffrey | Aug 1, 2023 | Sell | 55,710 | $19.63 | $1.1M |
What's the latest insider transaction for Exelixis?
The most recent insider transaction for Exelixis was conducted by Haley Patrick J., who sold 10,000 shares on March 3, 2025 at a price of $38.80 per share.
Which insider bought the most EXEL stock over the last two years?
Caligan Partners LP has bought the most EXEL stock in the last 2 years, with a total value of $15M.
Which insider has sold the most EXEL stock over the last two years?
Hessekiel Jeffrey has sold the most EXEL stock in the last 2 years, with a total value of $10M.
What is the total value of insider transactions for Exelixis (EXEL) in the last 2 years?
The total value of insider transactions for Exelixis in the last 2 years is negative, amounting to -$26M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Exelixis' market confidence?
Over the last 2 years, insider transactions for Exelixis have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
